Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. - Narod,S.A.; Brunet,J.S.; Ghadirian,P.; Robson,M.; Heimdal,K.; Neuhausen,S.L.; Stoppa-Lyonett,D.; Lerman,C.; Pasini,B.; de los Rios,P.; Weber,B.; Lynch,H. (Lancet, 2002)